• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • PDUFA Calendar
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page
When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

May 22, 2025 | Industry Trends, New Technology

Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team with their eye on the market.  Here at OZMOSI, we have been spending our summer building out a machine learning approach to further improve...

A Gift for Patients – Medicare to Cover Lung Cancer Screening

May 22, 2025 | Cancer, Industry Trends

LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by low-dose CT. ORIGINAL POST – Dec. 1, 2014 The Centers for Medicare & Medicaid Services (CMS) recently issued a proposal for Medicare to cover...
7 Small-Cap Biotech Companies to Watch at AACR in April

7 Small-Cap Biotech Companies to Watch at AACR in April

May 19, 2025 | Industry Trends, New Technology

We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which will take place April 5-10 in San Diego. The information...
Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April

Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April

May 19, 2025 | Industry Trends, New Technology

The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR will feature presentations from over 40 companies, covering roughly 80 innovative preclinical and clinical-stage programs targeting oncology...
Next Entries »

Recent Posts

  • Market Overview: GLP-1 Agonists and the Obesity MarketJune 12, 2025
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%June 12, 2025
  • Not Your Grandparents’ Probability of Success ForecastsJune 5, 2025
  • Clinical Trial Success Rates: What Makes Some Companies Stand Out?June 5, 2025
  • FDA Accelerated Approval, Breakthrough Therapy, and Fast Track Designations Supercharge Drug DevelopmentMay 26, 2025
  • Uncovering New Catalyst Events in the Pharmaceutical and Biotech MarketsMay 26, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde